Endothelial dysfunction and erectile dysfunction in the aging man. (Q37650850)

21 August 2017

1 reference

title

Endothelial dysfunction and erectile dysfunction in the aging man. (English)

1 reference

21 August 2017

0 references

1 reference

1

Antonio Aversa

1 reference

21 August 2017

Roberto Bruzziches

2

1 reference

21 August 2017

Davide Francomano

3

1 reference

21 August 2017

Marco Natali

4

1 reference

21 August 2017

Pietro Gareri

5

1 reference

21 August 2017

Giovanni Spera

6

1 reference

21 August 2017

language of work or name

1 reference

25 November 2009

1 reference

International Journal of Urology

21 August 2017

published in

1 reference

21 August 2017

volume

17

1 reference

21 August 2017

issue

1

1 reference

21 August 2017

page(s)

38-47

1 reference

The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02426.X

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02426.X

Metformin improves endothelial function in patients with metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02426.X

ED2: erectile dysfunction = endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02426.X

Erectile dysfunction as a predictor of cardiovascular events and death in diabetic patients with angiographically proven asymptomatic coronary artery disease: a potential protective role for statins and 5-phosphodiesterase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02426.X

Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02426.X

The pathogenesis of atherosclerosis: a perspective for the 1990s

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02426.X

The physiology of erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02426.X

Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02426.X

Endothelial dysfunction: a marker of atherosclerotic risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02426.X

Circulating cell adhesion molecules and death in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02426.X

Soluble intercellular adhesion molecule 1 and flow-mediated dilatation are related to the estimated risk of coronary heart disease independently from each other

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02426.X

The brain, the penis and steroid hormones: clinical correlates with endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02426.X

Coronary endothelial dysfunction is associated with erectile dysfunction and elevated asymmetric dimethylarginine in patients with early atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02426.X

ADMA (asymmetric dimethylarginine): an atherosclerotic disease mediating agent in patients with renal disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02426.X

Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02426.X

Plasma levels of asymmetrical dimethylarginine and adverse cardiovascular events after percutaneous coronary intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02426.X

Asymmetric dimethyl arginine levels correlate with cardiovascular risk factors in patients with erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02426.X

The assessment of endothelial function in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02426.X

Cross-sectional relations of digital vascular function to cardiovascular risk factors in the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02426.X

Endothelial and erectile dysfunction, diabetes mellitus, and the metabolic syndrome: common pathways and treatments?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02426.X

Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02426.X

Low testosterone level is an independent determinant of endothelial dysfunction in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02426.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02426.X

Relationship between androgenic hormones and arterial stiffness, based on longitudinal hormone measurements

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02426.X

Role of endogenous androgen against insulin resistance and athero- sclerosis in men with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02426.X

Low serum testosterone and mortality in older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02426.X

Association between plasma total testosterone and cardiovascular risk factors in healthy adult men: The Telecom Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02426.X

Association of plasma dehydroepiandrosterone-sulfate levels with endothelial function in postmenopausal women with coronary risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02426.X

Critical evaluation of hormonal therapy for carcinoma of the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02426.X

Long-term effects of androgen deprivation therapy in prostate cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02426.X

Androgen deprivation therapy in prostate cancer and metabolic risk for atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02426.X

Androgen deprivation therapy increases cardiovascular morbidity in men with prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02426.X

Androgen suppression and radiation vs radiation alone for prostate cancer: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02426.X

Endogenous testosterone and endothelial function in postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02426.X

Testosterone acts as a coronary vasodilator by a calcium antagonistic action

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02426.X

Testosterone-induced vasorelaxation in the rat mesenteric arterial bed is mediated predominantly via potassium channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02426.X

Testosterone might cause relaxation of human corpus cavernosum by potassium channel opening action

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02426.X

Effects of testosterone on sexual function in men: results of a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02426.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02426.X

The epidemiology of erectile dysfunction and its risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02426.X

Subclinical coronary artery atherosclerosis in patients with erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02426.X

Ageing is associated with impairment of nitric oxide and prostanoid dilator pathways in the human forearm

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02426.X

Detection of endothelial dysfunction with brachial artery ultrasound scanning

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02426.X

Assessment of endothelial function in Alzheimer's disease: is Alzheimer's disease a vascular disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02426.X

Significance of nitric oxide and its modulation mechanisms by endogenous nitric oxide synthase inhibitors and arginase in the micturition disorders and erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02426.X

Daily treatment with sildenafil reverses endothelial dysfunction and oxidative stress in an animal model of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02426.X

Chronic treatment with sildenafil improves energy balance and insulin action in high fat-fed conscious mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02426.X

Randomized, double-blind, placebo-controlled study of postoperative nightly sildenafil citrate for the prevention of erectile dysfunction after bilateral nerve-sparing radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02426.X

Effect of nightly versus on-demand vardenafil on recovery of erectile function in men following bilateral nerve-sparing radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02426.X

Comparable efficacy of once-daily versus on-demand vardenafil in men with mild-to-moderate erectile dysfunction: findings of the RESTORE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02426.X

Redefining the role of long-acting phosphodiesterase inhibitor tadalafil in the treatment of diabetic erectile dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02426.X

Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02426.X

Vascular damage as a risk factor for benign prostatic hyperplasia and erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02426.X

Lower urinary tract symptoms and sexual dysfunction: epidemiology and pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02426.X

2009 update on phosphodiesterase type 5 inhibitor therapy part 1: Recent studies on routine dosing for penile rehabilitation, lower urinary tract symptoms, and other indications (CME).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02426.X

Influence of Androgen Suppression Therapy for Prostate Cancer on the Frequency and Timing of Fatal Myocardial Infarctions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02426.X

10.1111/J.1442-2042.2009.02426.X

21 January 2018

Identifiers

DOI

1 reference

21 August 2017

1 reference